Skip to main content
. 2022 Jul 4;2022:8652062. doi: 10.1155/2022/8652062

Table 3.

Summarized the treatment regimen recommended from World Health Organization.

Diagnosis Population Medication Dose Duration
Paucibacillary leprosy
Adults
Rifampicin 600 mg/month 6 months
Clofazimine 300 mg/month + 50 mg/day 6 months
Dapsone 100 mg/day 6 months
Children (10–14 years)
Rifampicin 450 mg/month 6 months
Clofazimine 150 mg/month + 50 mg/day 6 months
Dapsone 50 mg/day 6 months
Children (<10 years old or <40 kg)
Rifampicin 10 mg/kg/month 6 months
Clofazimine 6 mg/kg/month + 1 mg/kg/day 6 months
Dapsone 2 mg/kg/daily 6 months
Multibacillary leprosy
Adult
Rifampicin 600 mg/month 12 months
Clofazimine 300 mg/month + 50 mg/day 12 months
Dapsone 100 mg/day 12 months
Children (10–14 years)
Rifampicin 450 mg/month 12 months
Clofazimine 150 mg/month + 50 mg/day 12 months
Dapsone 50 mg/day 12 months
Children (<10 years old or <40 kg
Rifampicin 10 mg/kg/month 12 months
Clofazimine 6 mg/kg/month + 1 mg/kg/day 12 months
Dapsone 2 mg/kg/daily 12 months